HLA-E*0103 & B2M

HLA-E*0103 & B2M Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (3)

  • Tag

    His Tag & Avi Tag (2)His Tag (1)

  • Conjugate

    Biotin-labeled (1)PE Labeled (1)Unconjugated (1)

HLA-E*0103 & B2M Background

HLA-E belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. HLA-E binds a restricted subset of peptides derived from the leader peptides of other class I molecules. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
AldaferminNGM-282; M70; M-70; NGM282Phase 2 ClinicalNgm Biopharmaceuticals IncLiver Cirrhosis, Biliary; Constipation; Irritable Bowel Syndrome; Metabolic Dysfunction-Associated Steatotic Liver Disease; Renal Insufficiency; Bile acid malabsorption (BAM); Fibrosis; Cholangitis, Sclerosing; Diarrhea; Hepatic Insufficiency; Malabsorption Syndromes; Diabetes Mellitus
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland